NeuroOne Medical Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NeuroOne Medical Technologies generated cash of -$11,011,840, which is more than the previous year. Cash used in financing activities reached the amount of $7,269,586 last year. Net change in cash is therefore -$3,862,451.
Cash Flow
| 2014 | -26.17K | 0 | 25.85K |
|---|---|---|---|
| 2015 | -30.22K | 0 | 30.02K |
| 2016 | -21.10K | 0 | 21.10K |
| 2017 | -2.10M | -91.70K | 1.70M |
| 2019 | -5.39M | -123.35K | 5.76M |
| 2020 | -3.42M | -122.42K | 7.32M |
| 2021 | -8.60M | -67.07K | 11.53M |
| 2022 | -7.51M | -3.24M | 12.02M |
| 2023 | -12.88M | 2.64M | 7.39M |
| 2024 | -11.01M | -120.19K | 7.26M |
NMTC Cash Flow Statement (2014 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.32M | 8.16M | 6.90M | 4.03M | 260.74K | 13.26K | 522.21K | 0 | 205 | 525 |
Operating activities | ||||||||||
Net income | -12.31M | -11.85M | -9.99M | -9.94M | -13.64M | -6.78M | -5.05M | -47.77K | -62.86K | -36.24K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 246.79K | 199.26K | 118.62K | 80.74K | 47.60K | 27.56K | 17.63K | 0 | 7.76K | 0 |
Stock-based compensation expense | 1.34M | 1.10M | 947.21K | 1.79M | 1.83M | 491.74K | 76.79K | 0 | 0 | 0 |
| Deferred income tax benefit | 1.34M | 1.10M | 947.21K | 1.79M | 1.83M | 491.74K | 76.79K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -176.63K | 33.23K | 15.09K | -48.33K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -908.46K | -1.02M | -606.25K | -98.28K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 66.99K | -247.18K | 515.43K | -350.31K | -269.60K | 770.61K | 0 | 11.50K | -2.10K | 0 |
Cash generated by operating activities | -11.01M | -12.88M | -7.51M | -8.60M | -3.42M | -5.39M | -2.10M | -21.10K | -30.22K | -26.17K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -1.47M | -3.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -120.19K | -384.11K | -275.22K | -67.07K | -122.42K | -123.35K | -91.70K | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 2.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -120.19K | 2.64M | -3.24M | -67.07K | -122.42K | -123.35K | -91.70K | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 5.87M | 8.59M | 13.35M | 8.82M | 390K | 4.56M | -40.59K | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -119.41K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -7.31M | -283K | 954.13K | 0 | 0 | 0 |
Cash used in financing activities | 7.26M | 7.39M | 12.02M | 11.53M | 7.32M | 5.76M | 1.70M | 21.10K | 30.02K | 25.85K |
Net Change In Cash | -3.86M | -2.83M | 1.25M | 2.86M | 3.77M | 247.48K | -495.75K | 0 | -205 | -320 |
Cash at end of period | 1.46M | 5.32M | 8.16M | 6.90M | 4.03M | 260.74K | 26.46K | 0 | 0 | 205 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |